These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3151103)

  • 1. Altered lymphocyte proliferation and cytokine release in hepatosplenic schistosomiasis mansoni in Brazil.
    Zwingenberger K; Jansen-Rosseck R; Cardoso AE; de Siqueira JG; Feldmeier H
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():273-6. PubMed ID: 3151103
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly.
    Tweardy DJ; Osman GS; el Kholy A; Ellner JJ
    J Clin Microbiol; 1987 May; 25(5):768-73. PubMed ID: 2953755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis.
    Abaza H; Asser L; el Sawy M; Wasfy S; Montaser L; Hagras M; Shaltout A
    Tissue Antigens; 1985 Nov; 26(5):307-9. PubMed ID: 3937292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
    Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H
    Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of immunosuppression in patients with hepatosplenic schistosomiasis mansoni.
    Tweardy DJ; Osman GS; El Kholy A; Ellner JJ
    Trans Assoc Am Physicians; 1983; 96():392-400. PubMed ID: 6238469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte subpopulation in early and late schistosomal hepatosplenomegaly.
    Hassan T; Mostafa A; Khalil R; Hassan O; Abd el Ghany S; Massoud S
    Chemioterapia; 1987 Jun; 6(2 Suppl):213-4. PubMed ID: 2978387
    [No Abstract]   [Full Text] [Related]  

  • 7. P38 mitogen-activated protein kinase influence on the production of IL-10 in human schistosomiasis mansoni.
    Carneiro-Santos P; Alves-Oliveira LF; Correa-Oliveira R; Hagan P
    Parasite Immunol; 2002; 24(9-10):493-7. PubMed ID: 12654092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific treatment of advanced schistosomiasis liver disease in man: favourable results.
    Coutinho A; Domingues AL
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():335-40. PubMed ID: 3151109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplantation and schistosomiasis mansoni.
    Azevedo LS; de Paula FJ; Ianhez LE; Saldanha LB; Sabbaga E
    Transplantation; 1987 Dec; 44(6):795-8. PubMed ID: 2962342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.
    Mwatha JK; Jones FM; Mohamed G; Naus CW; Riley EM; Butterworth AE; Kimani G; Kariuki CH; Ouma JH; Koech D; Dunne DW
    J Infect Dis; 2003 Apr; 187(8):1337-41. PubMed ID: 12696017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor in hepatosplenic schistosomiasis.
    Zwingenberger K; Irschick E; Vergetti Siqueira JG; Correia Dacal AR; Feldmeier H
    Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some immunological aspects on human Schistosoma mansoni infection in Egypt.
    el Marsafy A; el Okbi SM; el Adawy N
    J Egypt Soc Parasitol; 1993 Apr; 23(1):179-87. PubMed ID: 8482864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis.
    Wilson S; Jones FM; Mwatha JK; Kimani G; Booth M; Kariuki HC; Vennervald BJ; Ouma JH; Muchiri E; Dunne DW
    Parasite Immunol; 2009 Feb; 31(2):64-71. PubMed ID: 19149774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regression of the hepatosplenic form of schistosomiasis, after specific treatment, associated with race].
    Tavares-Neto J; Prata A
    Rev Soc Bras Med Trop; 1988; 21(3):131-3. PubMed ID: 3151132
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
    Zwingenberger K; Harms G; Feldmeier H; Müller O; Steiner A; Bienzle U
    Acta Trop; 1988 Sep; 45(3):263-75. PubMed ID: 2903628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of schistosomiasis mansoni in Zairian and Ugandan children of the Aru region in upper Zaire].
    Muller G; Murenzi JK; Tulu R
    Ann Soc Belg Med Trop; 1986 Sep; 66(3):225-33. PubMed ID: 3103554
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is glomerulopathy due to schistosomiasis mansoni disappearing?].
    Correia EI; Martinelli RP; Rocha H
    Rev Soc Bras Med Trop; 1997; 30(4):341-3. PubMed ID: 9265231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of liver and spleen enlargement in schistosomiasis mansoni infection in a rural Zambian community.
    Bulsara MK; Sukwa TY; Wurapa FK
    Trans R Soc Trop Med Hyg; 1985; 79(4):535-6. PubMed ID: 3936243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of reduced antibody response to "SMW68" (an affinity purified schistosomal antigen) with hepatosplenomegaly in Egyptian schoolchildren infected with Schistosoma mansoni.
    el-Hawey AM; Mahmoud AA; King CH; Amer ME
    J Egypt Soc Parasitol; 1990 Dec; 20(2):513-9. PubMed ID: 2121845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.